Rick Pazdur

Rare disease drugmakers to Congress: Don't gut the accelerated approval pathway
Endpoints
Tue, 08/3/21 - 11:02 am
FDA
Rick Pazdur
accelerated approvals
Biogen
Aduhelm
US Congress